z-logo
Premium
A fluorimetric assay for succinic semialdehyde dehydrogenase activity suitable for prenatal diagnosis of the enzyme deficiency
Author(s) -
Thorburn D. R.,
Thompson G. N.,
Howells D. W.
Publication year - 1993
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/bf00711509
Subject(s) - chemistry , biochemistry , enzyme , enzyme assay , prenatal diagnosis , fetus , biology , pregnancy , genetics
Summary Succinic semialdehyde dehydrogenase (SSAD) is an enzyme involved in the turnover of the neurotransmitter 4‐aminobutyrate (GABA). Deficiency of SSAD results in developmental delay, ataxia, seizures and 4‐hydroxybutyric aciduria. We have developed a simple fluorimetric assay for the enzyme and applied it to measurement of SSAD activity in a range of cell types often used for prenatal and postnatal diagnosis of enzyme defects. Lymphocytes from children with SSAD deficiency were found to have <5% of the activity found in lymphocytes from normal children. Heterozygotes are asymptomatic and have intermediate enzyme activities. Although SSAD activity has been detected previously in uncultured chorionic villi, we found that SSAD was not expressed in cultured chorionic villus cells nor in some fibroblast‐like amniocytes from control fetuses. Lymphocytes from fetal blood and non‐fibroblastic amniocytes have high SSAD activities, and should be suitable for prenatal diagnosis of SSAD deficiency.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here